EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.332
https://www.valueinhealthjournal.com/article/S1098-3015(22)02536-0/fulltext
Title : EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02536-0&doi=10.1016/j.jval.2022.09.332
First page :
Section Title :
Open access? : No
Section Order : 12137
Categories :
Tags :
Regions :
ViH Article Tags :